| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Neuropilin (NRPs) related pathological conditions and their modulators
Authors:ID Broz, Matic (Author)
ID Kolarič, Anja (Author)
ID Jukič, Marko (Author)
ID Bren, Urban (Author)
Files:.pdf Neuropilin_(NRPs)_Related_Pathologic-Broz-2022.pdf (11,93 MB)
MD5: FFF99CA8217077C2D8FF0BBE5D423850
 
URL https://www.mdpi.com/1422-0067/23/15/8402
 
Language:English
Work type:Scientific work
Typology:1.02 - Review Article
Organization:FKKT - Faculty of Chemistry and Chemical Engineering
Abstract:Neuropilin 1 (NRP1) represents one of the two homologous neuropilins (NRP, splice variants of neuropilin 2 are the other) found in all vertebrates. It forms a transmembrane glycoprotein distributed in many human body tissues as a (co)receptor for a variety of different ligands. In addition to its physiological role, it is also associated with various pathological conditions. Recently, NRP1 has been discovered as a coreceptor for the SARS-CoV-2 viral entry, along with ACE2, and has thus become one of the COVID-19 research foci. However, in addition to COVID-19, the current review also summarises its other pathological roles and its involvement in clinical diseases like cancer and neuropathic pain. We also discuss the diversity of native NRP ligands and perform a joint analysis. Last but not least, we review the therapeutic roles of NRP1 and introduce a series of NRP1 modulators, which are typical peptidomimetics or other small molecule antagonists, to provide the medicinal chemistry community with a state-of-the-art overview of neuropilin modulator design and NRP1 druggability assessment.
Keywords:neuropilins, computer-aided drug design, in silico drug design, receptor modulator design, peptidomimetics, small-molecule antagonists, cancer, COVID-19, neuropathic pain
Publication status:Published
Publication version:Version of Record
Submitted for review:24.06.2022
Article acceptance date:27.07.2022
Publication date:29.07.2022
Publisher:MDPI
Year of publishing:2022
Number of pages:23 str.
Numbering:Letn. 23, Št. 15
PID:20.500.12556/DKUM-85214 New window
UDC:577
ISSN on article:1422-0067
COBISS.SI-ID:118216451 New window
DOI:10.3390/ijms23158402 New window
Copyright:© 2022 by the authors
Publication date in DKUM:22.08.2023
Views:558
Downloads:381
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 New window

Document is financed by a project

Funder:ARRS - Slovenian Research Agency
Project number:P2-0046
Name:Separacijski procesi in produktna tehnika

Funder:ARRS - Slovenian Research Agency
Project number:P2-0438
Name:Optični kemijski/bio senzorski sistemi (OPTISENS)

Funder:ARRS - Slovenian Research Agency
Project number:J1-2471
Name:Kemijska karcinogeneza: Mehanistični vpogled

Funder:ARRS - Slovenian Research Agency
Project number:J1-1715
Name:Atlas proteinskih interakcij za napovedovanje genskih variacij povezanih z interakcijami z zdravili in razvojem bolezni

Funder:ARRS - Slovenian Research Agency
Project number:N1-0209
Name:Orodja za inovativno oblikovanje zdravil

Funder:ARRS - Slovenian Research Agency
Project number:P1-0403
Name:Računsko intenzivni kompleksni sistemi

Funder:the Slovenian Ministry of Education, Science and Sports
Funding programme:programme grant OP20.04342

Funder:the Slovenian Ministry of Science and Education
Funding programme:infrastructure project grants
Acronym:HPC-RIVR

Funder:the Slovenian Ministry of Science and Education
Funding programme:infrastructure project grants
Acronym:RI-SI-ELIXIR

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:neuropilini, peptidi


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica